Oral MS Drug Fampridine is Trifecta of Firsts for People with MS, Says National MS Society

Posted By: Anonymous | Posted On: Jan 21,2010 18:30 pm | View: 29 FDA approves fampridine SR, now called Ampyra, to improve walking for people with all types of multiple sclerosis. Ampyra is the first symptom management drug developed specifically to treat MS, the first oral therapy approved for MS and the first new FDA approved since 2004. Read More: http://www.prweb.com/releases/Ampyra/multiple_sclerosis/prweb3503694.htm